Allen R. Ritter is VP of Manufacturing/CMC at ENDOCYTE INC (ECYT). They have made 1 open-market trade across 1 company since 2012, most recently 2014-04-10.
CIK 0001509422
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 1 sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ECYT | 34,282 | $822K |
Shares reported on the most recent Form 4, priced at the 2014-04-11 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ECYT | SELL · 10b5-1 | 2014-04-09 | 2014-04-11 | $21.16 | $21K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2014-03-21 | 2014-03-24 | $33.11 | $265K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-09-16 | 2013-09-17 | $17.06 | $34K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL | 2013-08-30 | 2013-09-04 | $14.36 | $86K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-05-21 | 2013-05-22 | $14.17 | $7K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-05-07 | 2013-05-08 | $13.51 | $7K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-04-16 | 2013-04-18 | $13.22 | $7K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-04-02 | 2013-04-03 | $12.48 | $6K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-03-25 | 2013-03-27 | $11.00 | $11K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-02-15 | 2013-02-20 | $10.02 | $10K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2013-01-31 | 2013-02-04 | $10.00 | $10K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2012-12-18 | 2012-12-20 | $9.65 | $19K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2012-11-26 | 2012-11-27 | $9.00 | $18K | -24.6% | -0.5% | -0.5% |
| ECYT | SELL · 10b5-1 | 2012-11-01 | 2012-11-05 | $9.40 | $47K | -24.6% | -0.5% | -0.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.